Benchmark Electronics, Inc. · Technology · Electronic Components
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$77.44
−$4.26 (−5.21%) 4:00 PM ET
After hours$77.40
−$0.03 (−0.05%) 5:03 AM ET
Prev closePrevC$81.69
OpenOpen$80.29
Day highHigh$80.73
Day lowLow$76.97
VolumeVol640,495
Avg volAvgVol550,083
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$2.93B
P/E ratio
82.38
FY Revenue
$2.70B
EPS
0.94
Gross Margin
10.21%
Sector
Technology
AI report sections
MIXED
BHE
Benchmark Electronics, Inc.
Benchmark Electronics is trading near the top of its 52-week range after a sharp 12-month price appreciation of over 120%, supported by an uptrend above key moving averages but with some emerging short-term momentum cooling. Fundamentally, the company shows modest revenue growth with much faster net income and EPS expansion, yet profitability and free cash flow margins remain low. Valuation multiples such as the P/E and EV/EBITDA appear elevated relative to the company’s margin profile, while balance sheet liquidity and leverage metrics are conservative.
AI summarized at 2:01 AM ET, 2026-06-09
AI summary scores
INTRADAY:54SWING:72LONG:63
Volume vs average
Intraday (cumulative)
+59% (Above avg)
Vol/Avg: 1.59×
RSI
42.43(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.04 (Weak)
MACD: 0.02 Signal: 0.06
Short-Term
-1.34 (Weak)
MACD: -1.29 Signal: 0.05
Long-Term
-1.49 (Weak)
MACD: 1.85 Signal: 3.35
Intraday trend score
31.48
LOW31.48HIGH57.98
Latest news
BHE•10 articles•Positive: 3Neutral: 2Negative: 0
PositiveBenzinga• Lekha Gupta
Why Is Ouster Stock Soaring Monday?
Ouster (NASDAQ: OUST) stock surged nearly 8% in premarket trading on Monday following an expanded manufacturing partnership with Benchmark Electronics to scale production of its REV8 digital lidar sensors. The rally was also supported by a broader market recovery driven by improved risk appetite after a Trump-Iran peace agreement announcement. Technically, the stock remains in a strong uptrend, trading above its 20-day and 200-day moving averages, though momentum indicators show some cooling.
OUSTBHElidar sensorsmanufacturing partnershipREV8 digital lidarmarket rallytechnical analysismoving averages
Sentiment note
Expanded partnership with Ouster to support high-volume production of REV8 lidar sensors, leveraging its automated production capabilities and global network of 20 facilities. This represents a significant growth opportunity for the manufacturing partner.
PositiveGlobeNewswire Inc.• Sns Insider
Contract Manufacturing & Design Services Market Size to Hit USD 1441.89 Billion by 2032, at 9.8% CAGR | SNS Insider
The Contract Manufacturing and Design Services Market is projected to grow from USD 621.36 billion in 2024 to USD 1441.89 billion by 2032, driven by technological innovations like IoT, AI, and Industry 4.0, with Asia Pacific leading market expansion.
Part of leading market players in a rapidly growing industry with strong technological innovation potential
NeutralThe Motley Fool• Jesterai
Benchmark (BHE) Q2 EPS Beats by 2%
Benchmark Electronics reported Q2 2025 earnings with non-GAAP EPS of $0.55, slightly beating estimates. While revenue declined year-on-year, the company achieved multi-year record bookings and saw growth in semiconductor capital equipment and aerospace & defense sectors.
Mixed financial performance with slight earnings beat, record bookings, but year-on-year revenue decline and ongoing sector challenges indicate cautious outlook
NeutralGlobeNewswire Inc.• Researchandmarkets.Com
Telecom Electronic Manufacturing Services Industry 2024 - Focus on Green Manufacturing Initiatives in Telecom EMS Spurs Growth
The global Telecom Electronic Manufacturing Services (EMS) market is expected to grow from $213.4 billion in 2023 to $319.5 billion by 2030, driven by factors like increasing demand for telecom infrastructure, 5G network deployment, and the need for cost-efficient manufacturing solutions. The focus on green manufacturing initiatives in the telecom EMS industry is also contributing to market growth.
The article lists Benchmark Electronics, Inc. as one of the major players in the Telecom EMS market, but does not provide any additional details about the company's performance or prospects.
Benchmark Electronics (BHE) announced a quarterly cash dividend of $0.17 per share, payable on October 11, 2024, to shareholders of record on September 30, 2024.
BHEBenchmark Electronicsdividend
Sentiment note
The company announced a quarterly cash dividend, which is generally seen as a positive sign for shareholders.
UnknownBenzinga• Avi Kapoor
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday.
Shares of Oddity Tech Ltd. (NASDAQ: ODD) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter EPS results and issued FY24 EPS guidance below estimates.
ODDITY Tech posted earnings of 8 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $97.25 million versus expectations of $86.38 million, according to data from Benzinga Pro.
Oddity Tech shares tumbled 10.4% to $41.10 in pre-market ...
ROSTBHEEVCGRFSNewsPenny StocksSmall CapPre-Market Outlook
UnknownBenzinga• Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
Upgrades
According to Citigroup, the prior rating for Cyxtera Technologies Inc (NASDAQ:CYXT) was changed from Neutral to Buy. The current stock performance of Cyxtera Technologies shows a 52-week-high of $15.42 and a 52-week-low of $7.09. Moreover, at the end of the last trading period, the closing price was at $7.55.
For Centennial Resource Development Inc (NASDAQ:CDEV), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Centennial Resource Dev had an EPS of $0.60, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $9.70 and a 52-week-low of $5.08. Centennial Resource Dev closed at $7.74 at the end of the last trading period.
Wolfe Research upgraded the previous rating for Prologis Inc (NYSE:PLD) from Peer Perform to Outperform. In the second quarter, Prologis showed an EPS of $1.11, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $174.54 and a 52-week-low of $106.46. Prologis closed at $128.46 at the end of the last trading period.
For AvalonBay Communities Inc (NYSE:AVB), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the second quarter, AvalonBay Communities showed an EPS of $2.43, compared to $1.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $259.05 and a 52-week-low of $183.35. AvalonBay Communities closed at $206.67 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Roth Capital downgraded the previous rating of Buy to Neutral. For the second quarter, Catalyst Pharmaceuticals had an EPS of $0.28, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $15.07 and a 52-week-low of $5.24. Catalyst Pharmaceuticals closed at $14.91 at the end of the last trading period.
Truist Securities downgraded the previous rating for Aerie Pharmaceuticals Inc (NASDAQ:AERI) from Buy to Hold. For the second quarter, Aerie Pharmaceuticals had an EPS of $0.32, compared to year-ago quarter EPS of $0.84. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at ...Full story available on Benzinga.com
BHE earnings call for the period ending March 31, 2021.
BHEearningscall-transcripts
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
